Literature DB >> 16951046

Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.

Jason D Huber1, Reyna L VanGilder, Kimberly A Houser.   

Abstract

This study investigated the effects of streptozotocin-induced diabetes on the functional integrity of the blood-brain barrier in the rat at 7, 28, 56, and 90 days, using vascular space markers ranging in size from 342 to 65,000 Da. We also examined the effect of insulin treatment of diabetes on the formation and progression of cerebral microvascular damage and determined whether observed functional changes occurred globally throughout the brain or within specific brain regions. Results demonstrate that streptozotocin-induced diabetes produced a progressive increase in blood-brain barrier permeability to small molecules from 28 to 90 days and these changes in blood-brain barrier permeability were region specific, with the midbrain most susceptible to diabetes-induced microvascular damage. In addition, results showed that insulin treatment of diabetes attenuated blood-brain barrier disruption, especially during the first few weeks; however, as diabetes progressed, it was evident that microvascular damage occurred even when hyperglycemia was controlled. Overall, results of this study suggest that diabetes-induced perturbations to cerebral microvessels may disrupt homeostasis and contribute to long-term cognitive and functional deficits of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951046     DOI: 10.1152/ajpheart.00489.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  81 in total

Review 1.  Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.

Authors:  Wei-Ye Liu; Zhi-Bin Wang; Li-Chao Zhang; Xin Wei; Ling Li
Journal:  CNS Neurosci Ther       Date:  2012-06-12       Impact factor: 5.243

Review 2.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

3.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

Review 4.  Targeting the neurovascular unit for treatment of neurological disorders.

Authors:  Reyna L Vangilder; Charles L Rosen; Taura L Barr; Jason D Huber
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

Review 5.  From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.

Authors:  William A Banks
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

Review 6.  Mouse models of neurological disorders: a view from the blood-brain barrier.

Authors:  William A Banks
Journal:  Biochim Biophys Acta       Date:  2009-10-29

7.  Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Authors:  R L VanGilder; K A Kelly; M D Chua; R L Ptachcinski; Jason D Huber
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

8.  Comparative effects of glucose- and mannitol-induced osmolar stress on blood-brain barrier function in ovine fetuses and lambs.

Authors:  Barbara S Stonestreet; Grazyna B Sadowska; R Choudary Hanumara; Mihaela Petrache; Katherine H Petersson; Clifford S Patlak
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-31       Impact factor: 6.200

9.  Enhanced permeability responses to inflammation in streptozotocin-induced diabetic rat venules: Rho-mediated alterations of actin cytoskeleton and VE-cadherin.

Authors:  Dong Yuan; Sulei Xu; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

10.  Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment.

Authors:  Monica S Vavilala; Todd L Richards; Joan S Roberts; Harvey Chiu; Catherine Pihoker; Heidi Bradford; Kristina Deeter; Ken I Marro; Dennis Shaw
Journal:  Pediatr Crit Care Med       Date:  2010-05       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.